Annovis Bio (ANVS) Competitors

Anixa Biosciences (NASDAQ:ANIX) and Annovis Bio (NYSE:ANVS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

Is ANIX or ANVS more profitable?

Annovis Bio's return on equity of 0.00% beat Anixa Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anixa Biosciences	N/A	-58.55%	-53.29%
Annovis Bio	N/A	N/A	-311.00%

Do insiders & institutionals believe in ANIX or ANVS?

29.1% of Anixa Biosciences shares are owned by institutional investors. Comparatively, 15.8% of Annovis Bio shares are owned by institutional investors. 25.3% of Anixa Biosciences shares are owned by insiders. Comparatively, 32.3% of Annovis Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Do analysts rate ANIX or ANVS?

Anixa Biosciences presently has a consensus price target of $9.00, indicating a potential upside of 192.21%. Annovis Bio has a consensus price target of $37.00, indicating a potential upside of 1,910.87%. Given Annovis Bio's higher probable upside, analysts clearly believe Annovis Bio is more favorable than Anixa Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anixa Biosciences	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
Annovis Bio	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.00

Does the media favor ANIX or ANVS?

In the previous week, Anixa Biosciences had 10 more articles in the media than Annovis Bio. MarketBeat recorded 21 mentions for Anixa Biosciences and 11 mentions for Annovis Bio. Anixa Biosciences' average media sentiment score of 0.17 beat Annovis Bio's score of -0.26 indicating that Anixa Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anixa Biosciences	1 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral
Annovis Bio	1 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has better earnings and valuation, ANIX or ANVS?

Anixa Biosciences has higher revenue and earnings than Annovis Bio. Anixa Biosciences is trading at a lower price-to-earnings ratio than Annovis Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anixa Biosciences	$210K	472.22	-$12.55M	-$0.39	-7.90
Annovis Bio	N/A	N/A	-$56.20M	-$2.56	-0.72

Which has more volatility and risk, ANIX or ANVS?

Anixa Biosciences has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Annovis Bio has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500.

Does the MarketBeat Community believe in ANIX or ANVS?

Anixa Biosciences received 1 more outperform votes than Annovis Bio when rated by MarketBeat users. However, 93.75% of users gave Annovis Bio an outperform vote while only 75.61% of users gave Anixa Biosciences an outperform vote.

Company	Underperform	Outperform
Anixa Biosciences	Outperform Votes 31 75.61%	Underperform Votes 10 24.39%
Annovis Bio	Outperform Votes 30 93.75%	Underperform Votes 2 6.25%

Summary

Anixa Biosciences beats Annovis Bio on 9 of the 16 factors compared between the two stocks.